Our findings represent a novel negative regulation of MRP2, which may contribute to increased understanding of the decreased expression of MRP2 in cholestasis and may also provide new directions to explore in the development of novel therapeutic strategies for clinical treatment of cholestasis. The gene discussed is ABCC2; the disease is cholestasis.